Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salivary Flow and pH with Essential-Oil Mouthwashes
NCT06136455Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 2023
- Primary completion
- Nov 2023
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 4 trial of Cetylpyridinium chloride mouthwash in dental caries, gingivitis, sponsored by Johnson & Johnson. Started Nov 2023; status: completed.
02
Drugs
Cetylpyridinium chloride mouthwash
03
Conditions
dental cariesgingivitis
Beyond the preview
Go deeper on NCT06136455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06136455.